Join the club for FREE to access the whole archive and other member benefits.

Allogene Therapeutics

Clinical-stage biotechnology company pioneering the field of cell therapies

Allogene Therapeutics is a clinical-stage biotechnology company, focusing on pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer.

Developing off-the-shelf CAR T cell therapy candidates, with the goal of delivering readily available cell therapy faster, more reliably, and at greater scale to more patients. These off-the-shelf CAR T therapies, enhanced by gene editing, could be the next most important breakthrough in the field.

Allogene is on a mission to create and lead the next revolution in cancer treatment by delivering to patients the first AlloCAR T™ therapies for blood cancers and solid tumors.


Visit website: https://www.allogene.com/

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

Allogene Therapeutics News

FDA puts clinical hold on Allogenic CAR T therapy due to safety concerns

FierceBiotech - 08-Oct-2021

Chromosome abnormality reported in a clinical trial raises doubts on patient safety

Read more...